Peptide Purity Testing: How HPLC and Mass Spectrometry Work
How reverse-phase HPLC and mass spectrometry are used to test peptide purity and identity, how to read a chromatogram and a mass spectrum, and what each method cannot tell you.
Home / Research Library / Science Explained
A peptide certificate of analysis (COA) is the testing laboratory's record of what was measured on one specific batch: usually identity by mass spectrometry and purity by HPLC, and sometimes net peptide content, counter-ion, water and endotoxin. Read it in this order: does the identity match the compound named, what does the purity figure actually measure, how much of the powder is peptide, and who did the testing?
A COA is only as useful as your ability to check it. This guide walks through each section, what it can and cannot tell you, and the red flags that should make you stop and ask questions.
The peptide manufacturer Bachem frames quality control around four questions: is it the desired product, how pure is it, what by-products does it contain, and how high is the product content?1 A useful certificate answers them with data for the specific batch:
| Section | What it tells you | What to check |
|---|---|---|
| Compound, sequence, formula, theoretical mass | What the batch is supposed to be | Matches the product you ordered, residue by residue |
| Lot number and dates | Which batch was tested, and when | The lot matches your vial; the test date is plausible |
| Identity by mass spectrometry | The observed molecular mass | Agrees with the theoretical mass for that sequence |
| Purity by HPLC | Main-peak area as a percentage of all peaks | Method, wavelength and chromatogram are shown |
| Net peptide content | How much of the powder is peptide | Method stated, for example nitrogen analysis or amino acid analysis |
| Counter-ion | Salt form, such as trifluoroacetate or acetate | Relevant if you run cell-based assays |
| Water and residual solvents | Non-peptide mass | Karl Fischer titration; gas chromatography |
| Endotoxin (if stated) | Bacterial endotoxin level, often in EU/mg | The method is named and a number is given |
| Laboratory details | Who tested it | Laboratory name, approver, signature and date |
This is the first check and the easiest to fail. The sequence, molecular formula and mass on the certificate must belong to the compound on the vial. A certificate that shows a different sequence, a different formula or a mass belonging to another peptide is a red flag whatever its purity figure says, because high purity of the wrong molecule is worthless.
You can check the theoretical values yourself on PubChem. For example:
| Compound | Sequence | Formula | Molar mass (g/mol) | Monoisotopic mass (Da) |
|---|---|---|---|---|
| BPC-1572 | GEPPPGKPADDAGLV | C62H98N16O22 | 1419.5 | 1418.70 |
| Selank3 | TKPRPGP | C33H57N11O9 | 751.9 | 751.43 |
| Semax4 | MEHFPGP | C37H51N9O10S | 813.9 | 813.35 |
| DSIP5 | WAGGDASGE | C35H48N10O15 | 848.8 | 848.33 |
Two details trip people up. First, the average molar mass (used for weighing) and the monoisotopic mass (the lightest isotopic form, which high-resolution instruments report) are different numbers; for BPC-157 on PubChem the gap is about 0.8. Second, electrospray mass spectrometry produces a series of multiply charged ions6, so a spectrum may show its main peaks at m/z values well below the molecular mass. For BPC-157, the doubly protonated ion ([M+2H]2+) would appear near m/z 710.4. The certificate should either report the deconvoluted mass or say which charge state it is quoting. Our guide to HPLC and mass spectrometry explains these readouts in more detail.
An observed mass that differs from the expected value by the mass of one amino acid residue, one oxygen atom or a protecting group points to a specific synthesis or degradation impurity, such as a deletion sequence, an oxidised residue or incomplete deprotection, rather than the target peptide.7
For peptides, analytical HPLC with UV detection at 210–220 nm is the standard purity method, and "the area of the main peak in relation to the total area of all peaks reflects the peptide purity".1 A figure such as 98.6% therefore means that 98.6% of the UV-absorbing peak area, under those conditions, belongs to the main peak. It does not mean:
Ask for the chromatogram, not just the number. A certificate that states a purity but shows no trace, method, column or wavelength gives you nothing to check.

Higher is not automatically necessary, but it has to fit the use. Bachem's own grade guide recommends more than 95% purity for NMR and crystallography and for peptides used as references in quantitative enzyme–substrate, receptor–ligand and competition studies; 90–95% for quantitative assays, monoclonal antibody production and in vitro or in vivo studies; and more than 80% for qualitative work such as western blotting.1 It also notes that purity varies from batch to batch and that peptidic by-products in lower-purity batches can have biological activity of their own.1
Bachem defines net peptide content (NPC) as "the percentage of peptides relative to non-peptidic material (mostly counterions and moisture)", and stresses that "NPC and purity are not equivalent, because the former includes peptidic contaminants". It adds that basic peptides can have a low NPC even when extremely pure, because of salt formation, and that hydrophilic peptides can absorb considerable moisture.1 NPC is often estimated from nitrogen content by elemental analysis. Amino acid analysis, which breaks the peptide down with strong acid and quantifies the released amino acids, confirms composition but gives no sequence information.1
A 2024 test-purchase study shows why the distinction matters. Researchers made test purchases from illegal online pharmacies and analysed the three lyophilised semaglutide vials that were delivered, using liquid chromatography–mass spectrometry. Each chromatogram showed a single semaglutide signal with no peptide-like impurities, yet semaglutide made up only 7.7% to 14.4% of the powder's total weight, against the 99% purity claimed by the sellers. The semaglutide content per vial exceeded the labelled amount by 28.6% to 38.7%, and endotoxin was detected in all samples.10 A purity claim, a content figure and a label amount are three different numbers.
Peptides purified by reverse-phase HPLC are often isolated as trifluoroacetate (TFA) salts, because trifluoroacetic acid is part of the mobile phase.11 Bachem notes that TFA "cannot be completely removed due to salt formation" and suggests ordering a different salt form where residual TFA is a concern.1 It can be a concern. In cell culture, TFA at 10 to 100 nM reduced proliferation of osteoblasts and chondrocytes, and the TFA salts of amylin and calcitonin consistently gave less proliferation than the hydrochloride salts, enough to hide a proliferative effect or suggest an antiproliferative one that was not there.11 A review of counter-ions in peptides describes how the salt form also affects structure and physicochemical properties.12
Bachem lists the methods behind the rest of the non-peptide mass: water by Karl Fischer titration, residual solvents by gas chromatography, acetate by HPLC or ion chromatography, and residual TFA by ion chromatography.1 Together with NPC, these results explain the gap between a purity figure and the amount of peptide you can actually weigh out. Moisture also changes after the vial is opened, which is one reason storage matters; see how to store peptides.
An endotoxin result should name its method. The FDA's guidance on pyrogen and endotoxins testing (revised March 2026) describes the gel-clot, photometric and kinetic methods set out in USP chapter <85>, the Bacterial Endotoxins Test.13 Results are usually reported per milligram of material, for example in EU/mg. Sterility is a separate test: in the semaglutide study above, sterility and endotoxin were assessed under different pharmacopoeial chapters, and the samples were free of viable microorganisms yet still contained endotoxin.10 A certificate that reports one does not establish the other. For sterile handling at the bench, see reconstituting peptides aseptically.
Here is how the checks come together on a hypothetical certificate for 10 mg of angiotensin II, a peptide widely used as a laboratory standard. The certificate and its figures are invented for illustration; the reference values are PubChem's.14
| COA line (hypothetical) | Check | Verdict |
|---|---|---|
| Sequence DRVYIHPF; formula C50H71N13O12 | Matches the PubChem record for angiotensin II | The identity claim names the right molecule |
| ESI-MS, monoisotopic mass 1045.5 | Matches PubChem's monoisotopic mass of 1045.53 | Consistent |
| HPLC purity 98.2% at 220 nm, chromatogram attached | Wavelength and trace provided | Checkable |
| Net peptide content 78% (nitrogen analysis); counter-ion trifluoroacetate | About 7.8 mg of the 10 mg is peptide | Adjust stock concentrations accordingly |
| Lot number, test date, laboratory, signature | Lot matches the vial label | Traceable |
Change a single line and the verdict changes. A mass that does not match 1045.5, a sequence belonging to another peptide or a lot number that does not match the vial would each make the rest of the certificate irrelevant. For converting net peptide content into an accurate stock concentration, see the arithmetic in our guide to reconstituting peptides.
For what synthesis and lyophilisation leave in the vial in the first place, see what research peptides are and how they are made.
A peptide certificate of analysis (COA) is a laboratory report for one specific batch. It normally states the compound and sequence, the lot number, identity by mass spectrometry and purity by HPLC, and may add net peptide content, counter-ion, water, residual solvents and endotoxin. It should name the testing laboratory, the methods and the date, and include the underlying chromatogram and spectrum.
It depends on the experiment. Bachem's grade guide suggests above 95% for NMR, crystallography and reference use in quantitative studies such as receptor–ligand or enzyme–substrate work, 90–95% for many quantitative assays and in vitro or in vivo studies, and above 80% for qualitative work such as western blotting. Whatever the grade, identity has to be confirmed first.
Net peptide content is the percentage of the powder that is peptide rather than non-peptide material, mostly counter-ions such as trifluoroacetate and water. It is not the same as purity: purity comes from HPLC peak areas, while content is usually estimated from nitrogen analysis or amino acid analysis. Basic and hydrophilic peptides can have low net peptide content even when very pure.
No. HPLC purity is the main peak's share of UV-absorbing peak area, so water and counter-ions are not part of the figure. In a 2024 study of lyophilised semaglutide bought online, each sample showed a single semaglutide peak, yet semaglutide was only 7.7% to 14.4% of the powder's weight, against the 99% purity claimed by the sellers.
Check that the sequence, formula and mass match the compound named, that the lot number matches your vial, and that a chromatogram, mass spectrum, methods, laboratory name, signatory and date are all present. Identical data across different lots or compounds is a warning sign. If the laboratory offers a way to verify reports, use it, and confirm its accreditation covers that test.
How reverse-phase HPLC and mass spectrometry are used to test peptide purity and identity, how to read a chromatogram and a mass spectrum, and what each method cannot tell you.
What bacteriostatic water actually contains, how it compares with sterile water, when benzyl alcohol can interfere, and how to reconstitute a lyophilised peptide and calculate stock concentrations.
A laboratory guide to storing lyophilised and reconstituted peptides: freezer temperatures, moisture, oxidation-prone residues, light, freeze–thaw cycles and adsorption to containers.